Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...
Development is downsized from previous proposal for mixed-use with 137 units and ground-floor commercial space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results